Researchers conducted a systematic review and meta-analysis to examine whether taking statin medications is associated with developing sarcopenia in older adults. Sarcopenia is the age-related loss of muscle mass and strength. The analysis combined data from multiple studies, involving a total of over 9,000 participants aged 60 and older, primarily from European and Asian populations.
The main finding was that there was no statistically significant association between statin use and the development of sarcopenia. The combined result showed a pooled odds ratio of 0.82, but the confidence interval was very wide (95% CI: 0.16 to 4.05). This means the data from all the studies together suggests effects ranging from a possible mild protective effect to a possible harmful effect, but none were statistically clear.
It is very important to be cautious with this result. The review found extremely high heterogeneity (I² = 99.6%), meaning the individual studies included were very different from each other in their methods and findings. There was also limited consistency in how the studies were conducted. This makes the overall result difficult to interpret reliably.
Readers should understand that this analysis does not provide strong evidence that statins either cause or prevent sarcopenia in older adults. The evidence is observational, which means it can show a link but cannot prove cause and effect. The high variability between studies means more consistent, high-quality research is needed. If you are an older adult taking statins, do not stop or change your medication based on this review. Always discuss any concerns about muscle health with your doctor.